Cargando…
Olanzapine-Induced Hypertriglyceridemia Resulting in Necrotizing Pancreatitis
Olanzapine is an atypical antipsychotic agent that was approved by the Food and Drug Administration in 1996 for treatment of psychotic disorders, bipolar disorder, and schizophrenia. Since that time, numerous case reports have been published that describe the association of olanzapine and the develo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Gastroenterology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062670/ https://www.ncbi.nlm.nih.gov/pubmed/27807566 http://dx.doi.org/10.14309/crj.2016.77 |